Montréal and New York — Brookfield Asset Management (NYSE, TSX: BAM) through one of its private equity funds, together with its listed affiliate Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) and global investment group CDPQ, today announced that they have completed the acquisition of Antylia Scientific (“Antylia”) for approximately $1.3 billion. Antylia is a leading manufacturer and distributor […]

Transaction Follows Decade-Long Management Partnership Culminating in Successful Transformation and Growth of Unique Life Sciences Tools Business Chicago, IL — GTCR, a leading private equity firm, today announced that it has signed and completed the sale of Antylia Scientific (“Antylia” or “the Company”) to Brookfield Asset Management’s private equity business and CDPQ for approximately $1.34 […]

MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. The Aura™ platform from Halo Labs features a highly differentiated technology that performs full spectrum particle analysis and […]

BUCHI acquires Si-Ware Systems’ NeoSpectra Platform to establish a fully integrated quality assurance ecosystem based on NIR. BUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at key stages of the supply chain in food, feed, and chemicals industries Flawil, Switzerland – BÜCHI Labortechnik AG announces the acquisition of Si-Ware […]

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use, fast and flexible NGS data interpretation in a rapidly growing market Franklin complements QCI Interpret, QCI Precision Insights and QIAGEN’s leading genetic databases COSMIC and HGMD VENLO, […]

Closing unlocks the next phase of genomic medicine, enabling an end-to-end centralized and decentralized model for offering clinically-actionable genomic insights at a global scale GAITHERSBURG, Md. & OAKLAND, Calif.–GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the successful completion of its acquisition of Fabric Genomics, a pioneer in […]

Merger expands the platform’s technical capabilities and geographic reach into the Northeast corridor COLUMBUS, Ohio — Innovative Lab Services LLC (“ILS”), a premier provider of laboratory solutions, is proud to announce its acquisition of Compco Analytical, Inc (“Compco”) a well-established provider of analytical instrument maintenance and repair services based in New Jersey. This strategic combination […]

NEWARK, Calif. — CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, today announced the acquisition of BioChain, a leading provider of biospecimen collection, preparation, and analysis. The acquisition strengthens CellBio Scientific’s platform at a pivotal moment in drug discovery and development, as the industry focuses on using human-relevant research models […]

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 […]

Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today […]